SHORTCUTS
ESMO FAMILY SITES
Membership
The European Society for Medical Oncology (ESMO) is the leading European professional organisation, committed to advancing the specialty of medical oncology and promoting a multidisciplinary approach to cancer treatment and care.
To join ESMO is to join an international community of oncology professionals sharing best practices and the latest know-how in cancer treatment and care.
As a member, you can enjoy the benefits of educational opportunities and will be eligible to apply for ESMO fellowships, grants and awards and have the opportunity to develop your career through participation in ESMO's renowned scientific and educational programmes.
5 reasons to join the ESMO community today!
| Here are some of your most important advantages as an ESMO member (full list of membership benefits) | |
|
JOURNALSubscription to Annals of Oncology, the official journal of ESMO (12 issues per year, impact factor 6.452). Paper version and/or online access depending on membership category |
![]() |
ONCOLOGYPROAccess to OncologyPRO, a recently launched professional web portal brought exclusively to ESMO members. In collaboration with Thomson Reuters, ESMO present news, research, educational and scientific material, accessible via a powerful search engine. |
![]() |
EVENTS and CONGRESSESReduced registration fees for ESMO Congresses and meetings. Privileged participation in the scientific programme and exclusive access to webcasts for 3 months post events. |
![]() |
EDUCATIONBenefit from the full offer of ESMO educational material that range from ESMO Examination, CME tests and certifications, web-based practice tools, access to handbooks, guidelines, publications and the fellowship programmes. |
![]() |
NEWS and NETWORKSubscription to the e-news and scientific letter sent only to members; access to the Membership Directory, in order to network with your international colleagues. |
| Here are some of your most important advantages as an ESMO member (full list of membership benefits) | |







BACK TO TOP
PRINT THIS PAGE